Sacramento Bee: Sacramento's World-Renowned Infusion Lounge Celebrates Third Anniversary

From The Sacramento Bee:

At the epicenter of San Francisco's red hot nightclub scene, Infusion Lounge, one of the most popular and successful nightclubs on the West Coast, will celebrate its third year in San Francisco with an extraordinary Anniversary Celebration on Saturday, January 28, 2012.

As guests arrive on the paparazzi-lined red carpet, an ethereal garden of earthly delights will await them, including lusty garden decor, a tempting prix fixe dinner by Executive Chef Evan Turner, sizzling Top 40 mash-ups and house tracks provided by DJ Kevin Scott, live music, international talent, and plenty of surprises.

When it first opened its doors on New Year's Eve 2008, Infusion Lounge was the most lavish and expensive nightclub ever built in San Francisco. The exotic interior by award-winning nightclub designer Kinney Chan mesmerized guests with glowing latticed walls, hypnotic LED-lit towers, giant lacquer dragons, and luxurious furnishings. Infusion Lounge soon received the Diner's Choice Award from for its Pan-Asian cuisine.  Almost overnight it became known for its high-profile club nights featuring some of the biggest DJs from around the globe. Conde Nast Traveler Magazine quickly recognized it as one of the World's "Top 35" New Nightclubs.

Now three years later, sold-out crowds of young sophisticates and dancing hipsters continue to fill the 6500 sq. ft. subterranean entertainment space.  With its unparalleled bottle service and dedicated VIP Host, celebrities from sports, film, music and television are frequent guests, including P Diddy, Mary J Blige, LMFAO, Gerald Butler, Dave Chappelle, Mario Lopez, Vernon Davis, Lebron James, Terrell Owens, Tim Lincecum and many more.


For the full article, visit

Read more here:

Suggested Articles

A breakdown of the latest $1 trillion from the Senate.

The number of businesses switching from temporary to permanent closures surpasses 50%.

The coronavirus continues to threaten our industry but there are promising medical developments and still many questions on the next round of relief.